Conference Agenda

SAPHEX Conference - 23rd - 24th October 2019

SAPHEX is established as the go-to event for pharmaceutical manufacturers in the burgeoning South African & SADC market-place. At SAPHEX, the cream of pharmaceutical manufacturers meet the suppliers of technology and service solutions for their manufacturing & pharmaceutical endeavours in the exhibition hall, they learn best practice at the conference, and they get the opportunity to network with their peers to set up important business relationships.

Register Now
23rd October 2019
TimeTopicSpeaker
09:15 - 09:30Keynote AddressNicole Worthington, Lecturer - Mandela University
09:30 - 10:00Topic TBCSpeaker TBC
10:00 - 10:30Cannabis in South Africa: Flying high or coming down quickly?”Martha Smit, Bell Dewar Inc (Fasken)
10:30 - 11:00Destruction of MedicineMartin McClintock, A-Thermal Report Technologies (Pty) Ltd
11:00 - 11:30Break
11:30 - 12:00Topic TBCSebastian Girard, Global Business Development Manager - Eurotherm by Schneider Electric
12:00 - 12:30Global trends in GMPSheila Shadbolt, Cobalt Pharma Consultancy Ltd
12:30 - 13:30Lunch
13:30 - 14:00Topic TBCAbimbola Oshin, Sanofi Aventis Nigeria Ltd
14:00 - 14:30The patentability of living organisms and their genetic material Thomas Schmidt, Patent Specialist - KISCH IP
14:30 - 15:00The role of partnerships in harnessing investments.Ambassador Sadick Jaffer, Chief Director: Investment Promotion - Department of Trade and Industry (DTI), Invest SA
15:00 - 15:30Break
15:30 - 16:00Leveraging GS1 standards to ensure accuracy and safety of patient careMichele Francis Padayachee, GS1 South Africa
24th October 2019
TimeTopicSpeaker
09:15 - 09:30Keynote AddressSpeaker TBC
09:30 - 10:00Phytoextracts to manage Metabolic SyndromeMr. Mahesh LC, Sabinsa SA
10:00 - 10:30Local pharmaceutical industry in the context of 4IR (4th Industrial Revolution)Dr Motholic Godfrey Keele
10:30 - 11:00Topic TBCNicole Worthington
11:00 - 11:30Break
11:30 - 12:00Product liability matters in South AfricaSamantha Reyneke, Bell Dewar Inc (Fasken)
12:00 - 12:30Topic TBCSpeaker TBC
12:30 - 13:30Lunch
13:30 - 14:00Topic TBCSpeaker TBC
14:00 - 14:30Topic TBCSpeaker TBC
14:30 - 15:00Topic TBCSpeaker TBC
15:00 - 15:30Break
15:30 - 16:00Topic TBCSpeaker TBC
16:00 - 16:30Topic TBCSpeaker TBC
Register Now
Official Speakers
Martha Smit - Bell Dewar Inc (Fasken)
10:00 - 10:30
Cannabis in South Africa: Flying high or coming down quickly?”

Martha Smit is a partner in our Johannesburg office and a member of the firm’s Life Sciences practice group.

Qualified as both a registered nurse and lawyer, Martha brings compelling experience in the legal, medical and pharmaceutical industries.

Having practised as a litigation attorney and legal advisor in the corporate sector as well as coordinating clinical data trials for an international pharmaceutical company, she is able to bring the best of both worlds in finding innovative solutions for clients and businesses in the Life Sciences area.

Martha’s practical experience of having worked across a number of professional health bodies and corporates has afforded her first-hand knowledge and an in-depth understanding of the challenges, opportunities and regulatory environments of this sector.?

Martin McClintock - A-Thermal Report Technologies (Pty) Ltd
10:30 - 11:00
Topic TBC

Martin McClintock is an industrial Pharmacist specialising in the safe destruction of Pharmaceuticals in the best possible environmentally friendly way. Martin has completed B.Pharm in 2000 and M.Sc Pharm in 2002 at the Univeristy of North West in Potchefstroom. He has vast experience in the Formulation, Production, QC, QA, RA, Sale and Destruction of medicine and this gives him a broad understanding in most aspects of Pharmacy. Martin started assisting A-Thermal in August 2015 after being involved with destruction of medicine through his previous RP functions in both retail and industry. He enjoys the amount of legislation that is involved and is passionate about the issue of the Pharmacist’s responsibility and attitude toward responsible destruction of Pharmaceuticals as Custodians of Medication whilst being responsible towards the environment.

Sebastian Girard - KVM Tech
11:30 - 12:00
Topic TBC

Sébastien Girard joined Eurotherm in 1994 in the position of System Application Engineer, in 1999 as System Sales Engineer in the Lyon area. In 2002, he took on the leadership of the System Sales team and in 2006 he became Sales Leader for the North of France. In 2008, he was promoted to Sales Manager of France. In 2014 (Spain) & 2015 (Italy), he was further promoted to the Regional Sales Manager role for our Eurotherm Southern Europe Region.

Sébastien Girard is an active participant on the Gimelec association in France (Electrical Industry committee), he is member of the A3P association and of the ISPE association too.

Sébastien Girard has a long experience of more than 28 years on the Industry Automation business and specifically on Life Science development in Europe working close to many Key players implementing proven and innovative Eurotherm Automation solution to control their multiple processes.

Sébastien is committed to support and to engage our local team focus on Life Science customers and to deploy the Eurotherm Vision to this specific market. Sébastien will be very keen to meet you and to investigate with you how Eurotherm Value proposition will fit to your needs to develop your own sustainable Businesses.

Sheila Shadbolt - Cobalt Pharma Consultancy
12:00 - 12:30
Global trends in GMP

Sheila has an BSc and Molecular Biology and an MSc in Chemistry and is an experienced Quality professional with over 17 years’ experience in the pharmaceutical manufacturing environment in technical and quality leadership roles within both Quality Assurance and Quality Control. She has provided strategic Leadership of Quality organisations and GMP laboratory operations. She has practical experience of development and implementation of Quality Management Systems.

She has spent time supporting a large API facility and manufacturing operations of both human and veterinary products within parenteral, non-sterile liquid, Vaccines & Biological product manufacture. She has widespread knowledge and understanding of pharmaceutical production, plant design and operation.

Thomas Schmidt, Patent Specialist - KISCH IP
14:00 - 14:30
The patentability of living organisms and their genetic material

Thomas Schmidt is a patent specialist at KISCH IP with over 5 years’ experience in Intellectual Property law and patent prosecution. Before joining KISCH IP, he studied an MSc in plant biotechnology. Thomas has experience in drafting patent specifications, patent prosecution, patent searches, design filings and regulatory compliance issues related to biotechnology inventions. He has a specific interest in biotechnology-related innovation and product development, and has experience in plant and crop biotechnology, molecular biology, genetics, plant pathogens and genetically-modified crops.

Thomas is passionate about assisting clients in the research, development and commercialisation of their intellectual property, and in the use of data-driven analytics and searches to provide useful insights.

Mr. Mahesh LC - Sabinsa SA
09:30 - 10:00
Phytoextracts to manage Metabolic Syndrome

Mahesh is the Vice President – Business Development @ Sami Labs Limited-India and currently Heads the India Business Division. He is also the Technical domain partner to Sabinsa business in RSA and Australia.

With a progressive career spanning 25+ years in the field of Nutraceuticals, Cosmeceuticals and Dietary Supplements, he has made significant contributions to the Sami Sabinsa Group in terms conceptualization, innovation & development of new products, Business development and technical presentations at various national & international forums.

He is a dynamic, pro active leader with strong techno-commercial knowledge and works with a “Design to Delivery” approach.

Dr Motholic Godfrey Keele, President - SAAPI
10:00 - 10:30
Local pharmaceutical industry in the context of 4IR (4th Industrial Revolution)

Dr. Keele is a seasoned pharmaceutical executive with a career spanning the United Nations System, academia, pharmaceutical consultancy and the pharmaceutical industry where he is currently a Director of Corporate Affairs at Kiara Health. He is an ardent proponent of local production of pharmaceuticals on the African continent. Dr. Keele played a key role in facilitating access to markets on behalf of African based pharmaceutical companies. He was a leading part of a delegation of the Federation of African Pharmaceutical Manufacturers Associations (FAPMA) that met with The Global Fund in Geneva to secure a deal for procurement of pharmaceuticals from African based pharmaceutical companies for their donor-funded programmes. He was also appointed into a Technical Review Committee of the Southern African Development Community (SADC) that investigated the feasibility of regional production of pharmaceuticals within SADC. Dr. Keele is a sought-after speaker and a published author who is involved in applied research into industrial pharmacy in South Africa. He holds an Honorary Lecturer appointment from a premier African University, the University of the Witwatersrand. Dr. Keele is currently a President of the South African Association of Pharmacists in Industry and a Vice-President of the Pharmaceutical Society of South Africa.

Samantha Reyneke, Senior Associate - Bell Dewar Inc (Fasken)
11:30 - 12:00
Product liability matters in South Africa

Samantha Reyneke is a litigation and dispute resolution lawyer in Johannesburg, with a focus on construction law and product liability, as well as construction litigation and dispute adjudication on FIDIC contracts.

Primarily working for clients in the energy and power industries, Samantha acts for one of the largest contractors on South Africa’s two largest power expansion projects. She also represents international pharmaceutical companies in product liability cases relating to medical devices, and provides advice to the automotive industry and medical device manufacturers on product liability complaints.

Prior to joining Fasken, Samantha worked at the Competition Commission of South Africa as a Graduate Trainee and then as a member of the Antitrust/Competition and Marketing team. During her time at the regulator, she prepared merger notifications to local and international competition authorities, created exemption applications and appeals, and assisted in matters in the construction, infant milk formula, mining, steel, petroleum, and pharmaceutical industries.

Register Now

VISIT SOUTH AFRICA'S & SADC'S LARGEST PHARMACEUTICAL MANUFACTURING EVENT

Register to Visit SAPHEX 2019